Candel Therapeutics
CADL
CADL
22 hedge funds and large institutions have $5.92M invested in Candel Therapeutics in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4.26% less ownership
Funds ownership: 18.18% → 13.93% (-4.3%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Holders
22
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$31.9K | |
| 2 | +$27K | |
| 3 | +$24.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$17.5K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
+$14.7K |
Top Sellers
| 1 | -$1.05M | |
| 2 | -$207K | |
| 3 | -$30K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$22.5K |
| 5 |
EAM
Empirical Asset Management
Wellesley,
Massachusetts
|
-$9.2K |